Product Information
SUBOXONE 12 MG-3 MG SL FILM is a brand product labeled by Indivior Inc., priced at $17.1632 per EA under NDC 12496121203. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 30, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12; 3 mg/1; mg/1
Manufacturer
Indivior Inc.NDC
12496121203
Classification
Brand
Dosage Form
FILM, SOLUBLE
Route
BUCCAL; SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022410FDA Approved
8/30/2010
TE Code
AB
On Market Since
8/24/2012
Pharmacological Classes
Price Statistics
The NADAC for SUBOXONE 12 MG-3 MG SL FILM has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 26.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.1632 per EA |
|---|---|
| All-time high | $17.2697 (Jul 14, 2021) |
| All-time low | $13.5427 (Jun 17, 2015) |
| 52-week high | $17.1967 |
| 52-week low | $17.1632 |
| Median price | $17.1696 |
| Average price | $16.0318 |
| Largest weekly change | +5.0% (Jan 10, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the buprenorphine hydrochloride, naloxone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Indivior Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
buprenorphine hydrochloride, naloxone hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUBOXONE 12 MG-3 MG SL FILM?
The current National Average Drug Acquisition Cost (NADAC) for SUBOXONE 12 MG-3 MG SL FILM, manufactured by Indivior Inc., is $17.1632 per EA (NDC 12496121203), effective Sep 30, 2026.
How has the price of SUBOXONE 12 MG-3 MG SL FILM changed over time?
Over the history we have for it, the NADAC for SUBOXONE 12 MG-3 MG SL FILM has risen 26.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SUBOXONE 12 MG-3 MG SL FILM?
Since Nov 28, 2013, the NADAC for SUBOXONE 12 MG-3 MG SL FILM has ranged from a low of $13.5427 (Jun 17, 2015) to a high of $17.2697 (Jul 14, 2021), with a median of $17.1696 per EA.
Are there cheaper alternatives to SUBOXONE 12 MG-3 MG SL FILM?
No other NADAC-published product currently shares the active ingredient and strength of SUBOXONE 12 MG-3 MG SL FILM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SUBOXONE 12 MG-3 MG SL FILM?
SUBOXONE 12 MG-3 MG SL FILM (NDC 12496121203) is labeled by Indivior Inc., and CMS classifies it as a brand product.